Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT00072228 · WITHDRAWN
Trial details
- NCT number
- NCT00072228
- Sponsor
- Daiichi Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.